ydai3/LGSC-Abema-Ful-study: A Pilot Translational Study of Neoadjuvant Fulvestrant plus Abemaciclib in Women with Advanced Low-Grade Serous Carcinoma
Fuente:
Zenodo
Saved in:
| Main Author: | ydai3 |
|---|---|
| Format: | Recurso digital |
| Published: |
Zenodo
2026
|
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Developing Predictive and Robust Radiomics Models for Chemotherapy Response in High-Grade Serous Ovarian Carcinoma
by: Hatamikia, Sepideh, et al.
Published: (2026)
by: Hatamikia, Sepideh, et al.
Published: (2026)
Discriminating Chemoresistant and Chemosensitive Tubo‐Ovarian High‐Grade Serous Carcinoma Cells With Raman Microscopy
by: Elina Harju, et al.
Published: (2026)
by: Elina Harju, et al.
Published: (2026)
Immunoreactivities of ZCCHC3 and Efp in the High‐Grade Serous and Clear Cell Ovarian Carcinomas Are Worse Prognostic Factors
by: Erina Iwabuchi, et al.
Published: (2026)
by: Erina Iwabuchi, et al.
Published: (2026)
The Neoadjuvant Administration of PD‐1 Inhibitor plus Concurrent Chemoradiotherapy in Patients with Locally Advanced Esophageal Squamous‐Cell Carcinoma
by: Yong Chen, et al.
Published: (2024)
by: Yong Chen, et al.
Published: (2024)
The Expression and Clinical Significance of C1orf106 in Low‐Grade Serous Ovarian Cancer
by: Feifei Song, et al.
Published: (2025)
by: Feifei Song, et al.
Published: (2025)
A Case of Carcinosarcoma of the Peritoneum With Serous Tubal Intraepithelial Carcinoma
by: Akiko Kanemura, et al.
Published: (2024)
by: Akiko Kanemura, et al.
Published: (2024)
Vision Transformers for Preoperative CT-Based Prediction of Histopathologic Chemotherapy Response Score in High-Grade Serous Ovarian Carcinoma
by: Fati, Francesca, et al.
Published: (2026)
by: Fati, Francesca, et al.
Published: (2026)
Central Serous Chorioretinopathy Deteriorated With Everolimus Administration in Advanced Renal Cell Carcinoma: A Case Report
by: Mahdi Nemati, et al.
Published: (2026)
by: Mahdi Nemati, et al.
Published: (2026)
High‐Grade Serous Carcinoma With Focal Mesonephric‐Like Morphology and Subclonal p53 Abnormal Expression: A Potential Diagnostic Pitfall
by: Zitong Zhao, et al.
Published: (2025)
by: Zitong Zhao, et al.
Published: (2025)
A Novel Case of Indolent T‐Lymphoblastic Proliferation in Metastatic High‐Grade Serous Adenocarcinoma
by: Mia Dahl Sørensen, et al.
Published: (2025)
by: Mia Dahl Sørensen, et al.
Published: (2025)
Neoadjuvant Immunochemotherapy for Locally Advanced Oral Squamous Cell Carcinoma: A Case Report
by: Jiawen Li, et al.
Published: (2025)
by: Jiawen Li, et al.
Published: (2025)
Neoadjuvant tislelizumab plus pazopanib in renal cell carcinoma with venous tumour thrombus: A retrospective study
by: Diliyaer Dilixiati, et al.
Published: (2025)
by: Diliyaer Dilixiati, et al.
Published: (2025)
Case Report: Abemaciclib‐Induced Chronic Renal Failure
by: Lu Lin, et al.
Published: (2025)
by: Lu Lin, et al.
Published: (2025)
BeniFul: Backdoor Defense via Middle Feature Analysis for Deep Neural Networks
by: Li, Xinfu, et al.
Published: (2024)
by: Li, Xinfu, et al.
Published: (2024)
A Rare Presentation of Advanced‐Stage Low‐Grade Serous Carcinoma in a 27‐Year‐Old Patient. Navigating a Complex Postoperative Course: Submassive Pulmonary Embolism and a Large Retroperitoneal Haematoma Following Radical Ovarian Cytoreductive Surgery
by: Hannah Williams, et al.
Published: (2025)
by: Hannah Williams, et al.
Published: (2025)
Exploratory Biomarker Analysis of Abemaciclib in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma With Dysregulated CDK4 /6 Pathway
by: Joo‐Hwan Park, et al.
Published: (2026)
by: Joo‐Hwan Park, et al.
Published: (2026)
Population Pharmacokinetics and Exposure–Response Analyses for Capivasertib in Combination With Fulvestrant in Patients With Breast Cancer
by: Carlos Fernandez Teruel, et al.
Published: (2025)
by: Carlos Fernandez Teruel, et al.
Published: (2025)
Radiation Recall Dermatitis Associated With Abemaciclib Treatment for Breast Cancer
by: Corrado Zengarini, et al.
Published: (2025)
by: Corrado Zengarini, et al.
Published: (2025)
Treatment Strategy and Residual Disease as Determinants of Survival in Stage IVB High‐Grade Serous Ovarian Cancer: A Retrospective Cohort Study
by: Anouk Benseler, et al.
Published: (2025)
by: Anouk Benseler, et al.
Published: (2025)
Neoadjuvant Chemotherapy With Selpercatinib for Locally Advanced RET Fusion‐Positive Papillary Thyroid Carcinoma: A Case Report
by: Mei Kadoya, et al.
Published: (2025)
by: Mei Kadoya, et al.
Published: (2025)
Neoadjuvant Immunotherapy for Periauricular Cutaneous Squamous Cell Carcinoma
by: David Z. Allen, et al.
Published: (2025)
by: David Z. Allen, et al.
Published: (2025)
Human Papillomavirus (HPV) Type Distribution in Cervical Carcinoma, Low‐Grade, and High‐Grade Squamous Intraepithelial Lesions in Women Under 25 Years Old From the Largest Women Hospital in China
by: Yanmei Liu, et al.
Published: (2026)
by: Yanmei Liu, et al.
Published: (2026)
Causal Interplay Between Inflammatory Cytokines and Lipid Metabolites in Serous Ovarian Carcinoma: Insights From a Genetic Association Study
by: Chong‐ze Yang, et al.
Published: (2026)
by: Chong‐ze Yang, et al.
Published: (2026)
Efficacy of Neoadjuvant Immunochemotherapy in Pulmonary Lymphoepithelioma Carcinoma Compared With Lung Squamous Cell Carcinoma and Adenocarcinoma: A Retrospective Cohort Study
by: Weizhen Sun, et al.
Published: (2026)
by: Weizhen Sun, et al.
Published: (2026)
Subthreshold Micropulse Laser (577 nm) Therapy with an Individual Approach for Power Titration in Patients with Chronic Central Serous Chorioretinopathy (Pilot Study)
by: Taras Kustryn, et al.
Published: (2024)
by: Taras Kustryn, et al.
Published: (2024)
Constitutional BRCA1 Epimutations: A Key for Understanding Basal‐Like Breast and High‐Grade Serous Ovarian Cancer
by: Per E. Lønning, et al.
Published: (2024)
by: Per E. Lønning, et al.
Published: (2024)
Chapter 5 Leadership as Care-Ful Co-Directing Change: A Processual Approach to Ethical Leadership for Organizational Change
by: Andersson, Christoffer, et al.
Published: (2023)
by: Andersson, Christoffer, et al.
Published: (2023)
Tislelizumab Combined With Axitinib in Neoadjuvant Treatment of Locally Advanced Clear Cell Renal Cell Carcinoma: A Single‐Center, Phase II Clinical Study
by: Wenjin Yang, et al.
Published: (2026)
by: Wenjin Yang, et al.
Published: (2026)
Pulmonary Side Effects Associated With Abemaciclib the Antibreast Cancer Drug in Female Mice
by: Wajdan S. Alqahtani, et al.
Published: (2025)
by: Wajdan S. Alqahtani, et al.
Published: (2025)
Practice Patterns in Management of Low‐ to Intermediate‐Grade Salivary Gland Carcinoma: A Multi‐Institutional Study
by: Mirabelle Sajisevi, et al.
Published: (2025)
by: Mirabelle Sajisevi, et al.
Published: (2025)
Translational Advances in Urothelial Carcinoma: From Bench to Bedside
by: Tomohiro Iwasawa, et al.
Published: (2026)
by: Tomohiro Iwasawa, et al.
Published: (2026)
Survival and Perioperative Outcomes After Addition of Immunotherapy to Neoadjuvant Chemoradiotherapy for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma
by: Canjun Li, et al.
Published: (2025)
by: Canjun Li, et al.
Published: (2025)
Characteristic Hepatic Atrophy in Abemaciclib‐Induced Liver Injury: A Comparative Review of Three Cases
by: Yuwa Ando, et al.
Published: (2026)
by: Yuwa Ando, et al.
Published: (2026)
Dual Targeting of Tau Kinases and Autophagy by Abemaciclib Independent of CDK4/6 Inhibition
by: Jihui Han, et al.
Published: (2026)
by: Jihui Han, et al.
Published: (2026)
Metastatic Pancreatic Adenocarcinoma With Intraepithelial Spread to the Uterine Tube: A Diagnostic Challenge Simulating Serous Tubal Intraepithelial Carcinoma (STIC)
by: Javier A. Baena-Del Valle, et al.
Published: (2026)
by: Javier A. Baena-Del Valle, et al.
Published: (2026)
A Diachronic Study of Selected Translations by Indian Women Translators
by: Pradnyashailee Bhagwan Sawai
Published: (2018)
by: Pradnyashailee Bhagwan Sawai
Published: (2018)
“The Long Road to a Rare Destination”: Ovarian Serous Carcinoma With Late Thymic Metastasis 25 Years After Diagnosis
by: Nicole Fye, et al.
Published: (2026)
by: Nicole Fye, et al.
Published: (2026)
Neoadjuvant Intralesional Methotrexate for Squamous Cell Carcinoma of the Lower Lip: A Case Series
by: Caterina Mariarosaria Giorgio, et al.
Published: (2025)
by: Caterina Mariarosaria Giorgio, et al.
Published: (2025)
Emerging Trends in Neoadjuvant Immunotherapy for Hepatocellular Carcinoma: A Focus on Liver Transplant Candidates
by: Dongdong Yu, et al.
Published: (2025)
by: Dongdong Yu, et al.
Published: (2025)
Vacuum‐Assisted Excision and Assessing Residual Tumor Burden in Patients With Breast Cancer Following Neoadjuvant Chemotherapy (A Pilot Study)
by: Hawzhin Hashemi, et al.
Published: (2026)
by: Hawzhin Hashemi, et al.
Published: (2026)
Similar Items
-
Developing Predictive and Robust Radiomics Models for Chemotherapy Response in High-Grade Serous Ovarian Carcinoma
by: Hatamikia, Sepideh, et al.
Published: (2026) -
Discriminating Chemoresistant and Chemosensitive Tubo‐Ovarian High‐Grade Serous Carcinoma Cells With Raman Microscopy
by: Elina Harju, et al.
Published: (2026) -
Immunoreactivities of ZCCHC3 and Efp in the High‐Grade Serous and Clear Cell Ovarian Carcinomas Are Worse Prognostic Factors
by: Erina Iwabuchi, et al.
Published: (2026) -
The Neoadjuvant Administration of PD‐1 Inhibitor plus Concurrent Chemoradiotherapy in Patients with Locally Advanced Esophageal Squamous‐Cell Carcinoma
by: Yong Chen, et al.
Published: (2024) -
The Expression and Clinical Significance of C1orf106 in Low‐Grade Serous Ovarian Cancer
by: Feifei Song, et al.
Published: (2025)